Psyence Biomedical Ltd.

PBM | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.10

-$0.42 (-6.44%)

At close: Sep 22, 2026, 4:00 PM ET

$6.16

+$0.06 (+0.98%)

After-hours: Sep 22, 2026, 7:58 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-6.44%

(1D)

Rating

Updated: Aug 12, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $116.02K

1D Range

5.85 6.53

52W Range

1.92 175.78

Valuation (TTM)

PE 1.86

PB 0.01

EV/EBITDA 11.73

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -839.5%

SBC Adj. FCF Yield -839.6%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 115.8% | N/A

FCF 3Y | 5Y -55.7% | N/A

Returns

ROA -39.5%

ROE -58.6%

ROIC -36.8%

Financial Health

Net Cash

$7.2M

Current Ratio 14.62

Interest Coverage -655.06

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment di...

Sector Healthcare

Industry Biotechnology

Employees 12

IPO Date Dec 9, 2021

Website www.psyencebiomed.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.